Novartis AG (0QLR)
Market Closed
1 Aug, 15:30
LSE 
94. 18
CHF 0
0%
- Market Cap
- P/E Ratio
0% Div Yield
0 Volume
0 Eps
94.18 CHF
Previous Close Day Range
94.18 94.18
Year Range
81.22 115.98
Want to track 0QLR and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Earnings results expected in 84 days
| 0QLR Novartis AG 28 Oct 2025 (In 2 months) | | 2.23 Cons. EPS | - EPS |
| 0QLR Novartis AG 17 Jul 2025 | | 2.37 Cons. EPS | 1.7 EPS |
| 0QLR Novartis AG 21 Apr 2025 | | - Cons. EPS | - EPS |
| 0QLR Novartis AG 31 Jan 2025 | | - Cons. EPS | 1.23 EPS |
| 0QLR Novartis AG 29 Oct 2024 | | - Cons. EPS | 1.36 EPS |
| 0QLR Novartis AG 18 Jul 2024 | | - Cons. EPS | 1.44 EPS |
| 0QLR Novartis AG 20 Jun 2024 | | - Cons. EPS | 1.14 EPS |
| 0QLR Novartis AG 5 Jun 2024 | | - Cons. EPS | 1.14 EPS |
0QLR Earnings Reports FAQ
What is the earnings per share (EPS) for 0QLR?
The current EPS is 0.
What is the company's earnings growth rate?
Over the past 1 years, the earnings growth rate has been approximately 48.97%, reflecting the 0QLR's performance and LSE market conditions.
When is the next earnings release date?
The next earnings release is expected to be on 2025-10-28, based on the 0QLR's typical earnings announcement schedule.
What were the most recent quarterly earnings?
The most recent quarterly earnings were 1.7029 per share, reported on 2025-07-17. For dividend history, visit the 0QLR Dividends page.
What is the price-to-earnings (P/E) ratio?
The price-to-earnings (P/E) ratio is 55.31, calculated based on the most recent stock price of CHF94.18.
2025 © Marketlog. All Rights Reserved.
